CLINICAL_TRIALS
trial_result
· 2026-03-31
Clinical Trial Update: Multimodal Vasopressor Strategy in Septic Shock [Phase 2, Phase 3]
Summary
The document reports that a Phase 2/Phase 3 trial evaluating a multimodal vasopressor strategy for septic shock has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Medical Centre Maribor | Conditions: Shock, Septic | Phase 2, Phase 3 | Status: COMPLETED